• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Acute Graft Versus Host Disease

Acute Graft Versus Host Disease - 162 Studies Found

Terminated : Thymoglobulin (ATG) Dose Finding Study
: Graft vs Host Disease
: 2006-12-07
:
  • Drug: Low Dose Thymoglobulin (ATG)

Completed : Dendritic Cells in Patients With Acute or Chronic Skin Graft Versus Host Disease
:
  • Acute Graft-versus-host Disease
  • Acute GVH
    : 2015-11-12
    :
    • Procedure: Skin punch biopsy
    • Procedure: Pe

Completed : Acute Graft-Versus-Host Disease (aGvHD) Prophylaxis With ATG-Fresenius in Matched Unrelated Donor-Stem Cell Transplantation (MUD-SCT)
: Graft vs Host Disease
: 2008-04-03
: Drug: ATG-Fresenius S 20 mg rabbit immunoglobulin (IgG) in
Completed : MSC and Cyclophosphamide for Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis
:
  • Leukemia
  • Multiple Myeloma

: 2014-04-07
:
  • Drug: Cyclophosphamide Dose 50

Completed : Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention
:
  • Graft Versus Host Disease
  • GVHD

: 2015-10-26
:
  • Drug: Panobinostat Panobinosta

Completed : Mesenchymal Stem Cells as First Treatment Line for Resistant Acute Graft Versus Host Disease
: Graft vs Host Disease
: 2015-10-08
:
  • Biological: mesenchymal stem cells

Completed : Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease
: Graft Versus Host Disease
: 2003-02-05
:
  • Biological: Daclizumab Other N

Completed : High-Dose Cyclophosphamide in Treating Patients With Acute Graft-Versus-Host Disease That Did Not Respond to Steroid Therapy
: Graft Versus Host Disease
: 2007-06-25
:
  • Biological: filgrastim
  • Drug: cyclophospham

Terminated : Everolimus in Combination With Cyclosporine A and Prednisolone for the Treatment of Graft Versus Host Disease
: Graft Versus Host Disease
: 2006-09-06
: Drug: Everolimus
Completed : Carfilzomib for the Prevention of Graft Versus Host Disease
: Graft-versus-host Disease
: 2013-11-18
: Drug: carfilzumib carfilzumib will be added to the standard regimen of drugs for prevention of graft-ver
<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.